PharmAbcine Inc.
  1. Companies
  2. PharmAbcine Inc.
  3. Products
  4. PharmAbcine - Model PMC-309 - ...

PharmAbcineModel PMC-309 - Engineered Monoclonal Antibody

SHARE

PMC-309 is an engineered monoclonal antibody that targets the negative immune checkpoint human VISTA (V-domain Ig suppressor of T cell activation). It indirectly promotes T cells` immune responses by inhibiting VISTA-expressing immunosuppressive cells such as MDSCs (Myeloid-Derived Suppressor Cells) which suppress T cell inactivation and proliferation.

Most popular related searches
  • Solid tumors
  • The molecule`s mechanism and preclinical efficacies have been confirmed in human VISTA-KI mouse model. PharmAbcine initiated the GLP-tox study of PMC-309 in 2Q21 and expects an IND filing in 2Q22.